http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5726688-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1980-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07bebafc9f24687ff62686ce6b6dcab6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59ecda24c60b96a5ba391dad361b78cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcbb4fdd133a87f8814df0b7dd518df5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5742f5321fbc613a9e91149331f6b7f9
publicationDate 1982-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5726688-A
titleOfInvention Furo 3,2-b 1,8-naphthyridine-7-carboxylic acid derivative
abstract NEW MATERIAL:A 5,8-dihyrofuro or 2,3,5,8-tetrahydrofuro[ 3,2-b ]1,8-naphthyridine-7-carboxylic acid derivative (salt) shown by the formula I (R is H or lower alkyl). n EXAMPLE: 5, 8-Dihyro-5-( 2-hydroxyethyl )-8-oxofuro[ 3, 2-b ]1, 8-naph-thyridine- 7-carboxylic acid(salt). n USE: An antibacterial agent, a remedy for microbism, especially for uropathy. n PROCESS: For example, a compound shown by the formula II is formula II is heated with a dialkylformamide dialkyl acetal and a secondary amine to give an enamino compound, which is heated in an alcohol in the presence of an inorganic acid, e.g., hydrobromic acid, etc. to give an acetal derivative shown by the formula III. This derivative is treated with a Lewis acid, e.g., conc. sulfuric acid, etc. to give a furo[3,2-b]1,8-naph-thyridine derivative shown by the formula IV, and, if necessary, hydrolyzed and subjected to catalytic reduction. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5854376-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9023848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551990-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975892-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008046135-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8614212-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10233181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9573945-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5446109-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9133188-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017105818-A
priorityDate 1980-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420110850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID735156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428267050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236430532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70541988

Total number of triples: 46.